823 results
Page 6 of 42
6-K
EX-99.1
4big1k
13 Jul 22
Current report (foreign)
1:40pm
6-K
EX-99.2
32d8 re1v2nwrom9
13 Jul 22
Current report (foreign)
1:40pm
6-K
EX-99.1
tne5o4zbpeq y92ee
8 Jul 22
Sanofi Global Health launches nonprofit Impact® brand for 30 medicines in low-income countries
11:01am
6-K
EX-99.1
v6m6u3snm80rv08mfr
30 Jun 22
Current report (foreign)
12:10pm
6-K
EX-99.2
a9mwjhrr
28 Jun 22
Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine
3:59pm
6-K
EX-99.3
hvzuzmyjne
28 Jun 22
Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine
3:59pm
6-K
EX-99.1
jdencbozuqqmavh2g
28 Jun 22
Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine
3:59pm
6-K
EX-99.1
8hk5u0k 37y2i
16 Jun 22
Sanofi-GSK next-generation COVID-19 booster delivers strong immune response against variants of concern, including Omicron
1:20pm
6-K
EX-99.3
o3m56gledjockd24q73
13 Jun 22
FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 months to 5 years with moderate-to-severe atopic dermatitis
2:56pm
6-K
EX-99.1
h9tv5vwoa igx4lm3td
13 Jun 22
FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 months to 5 years with moderate-to-severe atopic dermatitis
2:56pm
6-K
EX-99.2
og528
13 Jun 22
FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 months to 5 years with moderate-to-severe atopic dermatitis
2:56pm
6-K
EX-99.1
2bn493j v6
7 Jun 22
Current report (foreign)
2:51pm
6-K
EX-99.2
t9xkr4moph8tyo
7 Jun 22
Current report (foreign)
2:51pm
6-K
EX-99.3
1yo2mw7
7 Jun 22
Current report (foreign)
2:51pm
6-K
EX-99.1
1w1cx6g
31 May 22
Update on Cialis® Rx-to-OTC Switch Actual Use Trial
10:56am
6-K
EX-99.2
ikg4u td2tkmrgm3
31 May 22
Update on Cialis® Rx-to-OTC Switch Actual Use Trial
10:56am
6-K
EX-99.1
rx5e9ol7q7m
25 May 22
FDA approves Dupixent® (dupilumab) as first treatment for adults and children aged 12 and older with eosinophilic esophagitis
1:53pm
6-K
EX-99.1
m0rk5p 8fx
17 May 22
Current report (foreign)
3:20pm
6-K
EX-99.2
nd3lak 9tmso
17 May 22
Current report (foreign)
3:20pm
6-K
EX-99.1
1ao0dl5rp37
16 May 22
IFRS net sales reported
1:45pm